Peripherally depleted in severe illness (127); effector functions (primarily TNFα and IL-17A production) altered in COVID-19 (128) in one study, with heightened activation and cytotoxic phenotypes seen in another study (129) correlating with severity of disease. Here, IL17A is linked to COVID-19.